Eagle Bay Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-80	Closed	-$84.1K	–	1040
2024 Q3	$84.1K	Sell	80 -1	-1%	-$1.11K	0.03%	345
2024 Q2	$85.1K	Sell	81 -1	-1%	-$969	0.05%	256
2024 Q1	$78.9K	Sell	82 -2	-2%	-$1.9K	0.05%	247
2023 Q4	$73.8K	Sell	84 -1	-1%	-$823	0.05%	250
2023 Q3	$70K	Sell	85 -1	-1%	-$786	0.03%	337
2023 Q2	$61.8K	Buy	86 +2	+2%	+$1.54K	0.04%	329
2023 Q1	$69K	Sell	84 -5	-6%	-$3.77K	0.04%	316
2022 Q4	$64.2K	Sell	89 -7	-7%	-$5.17K	0.04%	326
2022 Q3	$66K	Sell	96 -6	-6%	-$3.78K	0.04%	288
2022 Q2	$60.3K	Buy	+102	New	+$66.3K	0.04%	319
2022 Q1	–	Sell	-109	Closed	-$69K	–	831
2021 Q4	$69K	Sell	109 -102	-48%	-$62.7K	0.05%	274
2021 Q3	$128K	Buy	211 +105	+99%	+$65.2K	0.07%	193
2021 Q2	$61K	Buy	+106	New	+$53.7K	0.05%	275